BioSpace News Archive

Policy

PhotoniCare Announces FDA Clearance for First-In-Class Technology for Imaging the Ear

TOMi Scope allows physicians, for the first time ever, to non-invasively view fluid directly in the middle ear, even in the presence of wax build-up

January 6, 2020
·
4 min read
Global Galacto-Oligosaccharide Market to Grow by 498.15 Million During 2020-2024 | Evolving Opportunities with Baolingbao Biology Co. Ltd. and Clasado BioSciences | Technavio

Technavio has announced its latest market research report titled global galacto-oligosaccharide market 2020-2024.

January 6, 2020
·
4 min read
Genetown

Alexion to Present at the 38th Annual J.P Morgan Healthcare Conference

Alexion Pharmaceuticals announced that management will present at the 38th Annual J.P Morgan Healthcare Conference in San Francisco, CA on Tuesday, January 14th, 2019 at 7:30 a.m, PT. A breakout question and answer session will immediately follow the formal presentation.

January 6, 2020
·
1 min read
Job Trends

Seagate’s Lyve Drive Mobile System Activates the Datasphere at CES 2020

Revolutionary Modular Storage System Built to Efficiently Manage Enterprise, Cloud, and Edge Data Growth

January 6, 2020
·
7 min read
Deals

Slayback Pharma announces investment of $50 million by The Everstone Group

Slayback Pharma LLC announced an agreement with The Everstone Group to invest up to US$50 million in Series B funding.

January 6, 2020
·
3 min read
Biotech Bay

IDEAYA Biosciences to Present at the 38th Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2020

IDEAYA Biosciences, Inc. announced that the company is scheduled to present at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 15, 2020 at 5:00 p.m. PT.

January 6, 2020
·
2 min read
Deals

Epizyme Announces Exercise of $50 Million Option with Royalty Pharma and Highlights Key 2020 Initiatives to Build Long-Term Value

Epizyme, Inc. announced that it exercised its option to sell $50 million of its common stock to Royalty Pharma, pursuant to the terms of the companies’ recent funding agreements announced on November 4, 2019.

January 6, 2020
·
6 min read
Pharm Country

Lannett Launches Venlafaxine ER Tablets And Lidocaine Topical Solution 4%

Lannett Company, Inc. announced that it has commenced marketing Venlafaxine Extended Release Tablets, 150 mg and 225 mg, USP, and Lidocaine Topical Solution 4%.

January 6, 2020
·
1 min read
Deals

Osmotica Announces Proposed Public Offering of Ordinary Shares

Osmotica Pharmaceuticals plc, a fully integrated biopharmaceutical company, announced the commencement of a proposed public offering of 6,000,000 ordinary shares.

January 6, 2020
·
3 min read
Business

TransEnterix Provides 2019 Year End Corporate Update

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today provided a year-end corporate update.

January 6, 2020
·
6 min read